Delta Neutrophil Index and Neutrophil Lymphocyte Ratio in Thyroid Malignancy
NCT04425512 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 333
Last updated 2020-06-11
Summary
Thyroid surgery is the most common surgical procedure among endocrine surgeries. It is performed in patients with suspected malignancy, patients diagnosed with malignancy, and for toxic nodular goiter \[1\]. Fine-needle aspiration biopsy (FNAB) is used as a daily technique in preoperative evaluation to differentiate malignant and benign nodules. However, complications including hematoma formation, tumor transplantation along the needle trace, thyroid nodule infarction and vascular proliferation can be seen even in this minimally invasive procedure \[2\]. Therefore, the differentiation of benign and malignant groups using non-interventional methods before surgery has become important.
Cancer-related inflammation, including papillary thyroid carcinoma, is involved in carcinogenesis and progression of neoplastic disease \[3,4\]. Neutrophils induced by the tumor can accelerate tumor metastasis \[3,5\]. Lymphocytes, as the cornerstone of the adaptive immune system, inhibit tumor cell proliferation and migration as well as destroying metastases \[3,6\]. Previous studies have shown that increased lymphocyte count has a positive effect on better survival in patients with advanced cancer \[7\]. Furthermore, Kupffer cells, also known as liver macrophages, destroy circulating cancer cells and help the distribution of tumor cells via circulation. Therefore, routine blood tests have been investigated as a predictive or prognostic factor for carcinomas since blood parameters in these tests show whether there is inflammation. Neutrophil count, lymphocyte count, neutrophil-lymphocyte ratio (NLR), lymphocyte-monocyte ratio (LMR), mean platelet volume (MPV), and platelet distribution width (PDW) have been studied in terms of numerous malignancies \[3\].
Tumor-related inflammation is activated the bone marrow and inflammation induced by malignancies. Inflammatory activity that is poorly controlled or uncontrollable may be responsible for malignant transformation \[8\]. At this point, NLR has previously been shown to be useful in the differentiation of thyroid malignancies and benign thyroid diseases \[9\]. Delta neutrophil index (DNI) / increased number of immature granulocytes (IG) represents active bone marrow. Delta neutrophil index, which is manifested by IG formation in inflammatory and infectious events, shows changes in the white blood cell count \[10\].
This study aimed to evaluate the relation between the automatically calculated DNI/IG count and manually calculated NLR from the preoperative complete blood count (CB) parameters, and thyroid malignancies with a cost-effective non-invasive method before surgery or biopsy as the indicator of the malignant inflammatory response in the differentiation of nodular goiter and thyroid malignancy.
Conditions
- Thyroid Cancer
- Thyroid Nodule
- Thyroid Diseases
- Delta Neutrophyl Index
- Immature Granulocyte Count
- Neutrophyl to Lymphocyte Ratio
Interventions
- DIAGNOSTIC_TEST
-
Complete Blood Count
Complete Blood Count samples
Sponsors & Collaborators
-
Kahramanmaras Sutcu Imam University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2014-11-01
- Primary Completion
- 2019-11-01
- Completion
- 2019-11-01
More Related Trials
-
Clinical Diagnostic Approach for Cases of Thyroid Nodules
NCT03884140 ·Status: UNKNOWN
-
The Usefulness of Staining Lymph Nodes During Operations for Cancer Thyroid in Detecting the Nodes That Have Cancer
NCT00794053 ·Status: COMPLETED ·Phase: PHASE3
-
Near-infrared Fluorescence With Indocyanine Green for Identification of Sentinels and Parathyroids During Thyroidectomy
NCT04424485 ·Status: UNKNOWN ·Phase: NA
-
Outcome of RAI131 Therapy in Patients With Differentiated Thyroid Cancer (Low and Intermediate Risk)
NCT07056218 ·Status: NOT_YET_RECRUITING
-
Assessment of Repeat Fine Needle Aspiration (FNA) to Detect Thyroid Cancer
NCT00954837 ·Status: WITHDRAWN ·Phase: NA
-
Elastography in Thyroid Nodules
NCT04312646 ·Status: UNKNOWN
-
OnT4-Thyroglobulin Assay Before rhTSH-Aided Radioiodine Ablation
NCT00439127 ·Status: COMPLETED
-
The Impact of Contrast Media Used in Epidural Steroid Injections on Thyroid Function Tests
NCT05404412 ·Status: COMPLETED
-
The Role of Midkine in Diagnosis of Thyroid Cancer
NCT03978351 ·Status: UNKNOWN
-
Three-dimensional Thyroid Education Model
NCT06146998 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Iron Deficiency Anemia Can be an Indication for Treatment of Subclinical Hypothyroidism
NCT00535561 ·Status: COMPLETED ·Phase: PHASE1
-
Intra-operative Rapid Identification of Lymph Node and Parathyroid
NCT03268785 ·Status: UNKNOWN ·Phase: NA
-
Effects of Radioactive Iodine on the Immune System in Thyroid Cancer
NCT05989555 ·Status: NOT_YET_RECRUITING
-
Urinary Exosomal Biomarkers of Thyroglobulin and Galectin-3 for Prognosis and Follow-up in Patients of Thyroid Cancer
NCT04948437 ·Status: ACTIVE_NOT_RECRUITING
-
Diagnostic Accuracy Study of Indocyanine Green for Parathyroid Perfusion Assessment
NCT03969108 ·Status: COMPLETED ·Phase: PHASE4
-
Prediction of Thyroid Cancer From Ultrasonographic Characteristics of Thyroid Nodules
NCT00571090 ·Status: COMPLETED
-
Evaluation of DNA Methylation Signatures for the Diagnosis and Management of Thyroid Nodules
NCT05229341 ·Status: RECRUITING ·Phase: NA
-
Electrical Impedance Scanning of Thyroid Nodules Prior to Thyroid Surgery: a Prospective Study
NCT00571077 ·Status: COMPLETED
-
Predictive Factors of Clinical, Laboratory and Imaging Findings Routinely Used in Diagnosing Thyroid Cancer
NCT01074684 ·Status: COMPLETED
-
Long Non Coding RNA HOTAIR and Midkine as Biomarkers in Thyroid Cancer
NCT03469544 ·Status: UNKNOWN
-
Thyroglobulin Point of Care Assay for Rapid Detection of Metastatic Differentiated Thyroid Carcinoma
NCT05078853 ·Status: COMPLETED
-
Predicting Prognosis and Recurrence of Thyroid Cancer Via New Biomarkers, Urinary Exosomal Thyroglobulin and Galectin-3
NCT03488134 ·Status: COMPLETED
-
Role of Preoperative Serum Thyroglobulin Level to Differentiate Between Different Thyroid Nodules
NCT06157632 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Extent of Central Lymph Node Dissection in Papillary Thyroid Microcarcinoma
NCT01149161 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Thyroid Function Tests and Status of Thyroid Autoantibodies in Covid-19 Patients
NCT04659200 ·Status: COMPLETED